Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Cancer Prev Res (Phila). 2011 Jun 16;4(9):1419–1425. doi: 10.1158/1940-6207.CAPR-11-0148

Table 1.

Demographics for patients randomised to 5.0 g/day SRT501 and placebo

SRT501
(n=6)
 Placebo
(n=3)
   Age (years) 68.5(±10.8)  64.3(±6.35)
   Gender M: 5 M: 1
F: 1 F: 2
   BMI 28.10(±4.35)  26.87(±1.61)
   Race
(100%)
Caucasian (100%) Caucasian
   Days on study 13.3(±1.03)  14.0(±0.00)
   Cumulative dose per subject (g) 66.7(±5.16)  70.0(±0.00)

BMI: body mass index; F: female; M: male.